The First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade1-3Oct 8, 20241 min readClick here to learn more and register!11-7-24 Davios Boston- Fruzaqla Dinner Talk Invitation.pdfDownload PDF • 847KB
NEW Event! From Mutation to Management: Practical Nursing Strategies in HER2-Mutant NSCLC ~ 5.14.26 @ ONS Congress
Comments